carbidopa has been researched along with Neuroblastoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frakolaki, E; Gkogkosi, P; Paspaltsis, I; Siaterli, MZ; Sklaviadis, T; Vassilacopoulou, D; Vassilaki, N; Vassiliou, AG | 1 |
Colamartino, M; Cornetta, T; Cozzi, R; Leone, S; Meneghini, C; Padua, L; Testa, A | 1 |
Chiti, A; D'Ambrosio, D; Fanti, S; Lopci, E; Marengo, M; Nanni, C; Pession, A | 1 |
Anton, AH; Crumrine, RS; Izant, RJ; Stern, RC | 1 |
Canals, S; Casarejos, MJ; de Bernardo, S; Handler, A; Mena, MA; Rodríguez-Martín, E | 1 |
1 trial(s) available for carbidopa and Neuroblastoma
Article | Year |
---|---|
Feasibility of carbidopa premedication in pediatric patients: a pilot study.
Topics: Carbidopa; Child; Child, Preschool; Dihydroxyphenylalanine; Drug Interactions; Female; Fluorine Radioisotopes; Humans; Male; Neuroblastoma; Pilot Projects; Premedication; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
4 other study(ies) available for carbidopa and Neuroblastoma
Article | Year |
---|---|
L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Carcinoma, Hepatocellular; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neuroblastoma; Peptide Fragments; Peptide Library; Phosphatidylinositol 3-Kinases; Tumor Cells, Cultured | 2019 |
Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Dopa Decarboxylase; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Levodopa; Neuroblastoma; Oxidants; Oxidative Stress; Reactive Oxygen Species; Time Factors | 2012 |
Inhibition of catecholamine biosynthesis by carbidopa and metyrosine in neuroblastoma.
Topics: alpha-Methyltyrosine; Carbidopa; Catecholamines; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Female; Homovanillic Acid; Humans; Infant; Male; Methyltyrosines; Neuroblastoma; Norepinephrine; Vanilmandelic Acid | 1983 |
L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells.
Topics: Antioxidants; Apoptosis; Ascorbic Acid; bcl-X Protein; Buthionine Sulfoximine; Carbidopa; Cell Differentiation; Culture Media, Conditioned; Culture Media, Serum-Free; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione; Humans; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Levodopa; Neuroblastoma; Neuroglia; Neurons; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 2001 |